CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
about
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus EncephalitisAllogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factorsCD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responsesIL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditionsThe principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils.Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.Review article: molecular signals and genetic reprogramming in peripheral T-cell differentiation.A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40LAutoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 GTim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicityMagnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia.Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.CD40 ligand deficiency: neurologic sequelae with radiographic correlationDevelopment of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease.Immunotherapy exploiting the versatility of dendritic cells.Dendritic-tumor fusion cells derived heat shock protein70-peptide complex has enhanced immunogenicity.Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli.High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection.CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment.Tumor-infiltrating T lymphocytes: friends or foes?Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progressionEscape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation.Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.The Tower of Babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters, and possible dead ends.Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions.Potent tumor-specific protection ignited by adoptively transferred CD4+ T cellsInduction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 miceIdentification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells.Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.T cell response and persistence of the microsporidia.Current and emerging immunotherapeutic approaches to treat and prevent peanut allergy.Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells.Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population.Antitumor activity of chimeric immunoreceptor gene-modified Tc1 and Th1 cells against autologous carcinoembryonic antigen-expressing colon cancer cells.Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells.
P2860
Q27469893-4F77F94E-6703-4033-B2D7-72E800F50765Q27481468-DB96E2BA-B3A3-425C-920D-583C9ADD1D67Q28652288-714D997E-CBDF-44DB-9654-575AD0176123Q30433070-688C1F68-09E9-4CEC-9A70-6395E81976ABQ33697777-AB1F29BC-8B23-4A6F-B953-EEC586D49427Q33943143-E3297838-DAF9-4FC5-8453-7DCE76F4EED6Q34056413-2FBE48F4-9B85-4EB1-A8AB-4B1CD0794730Q34094070-BA616EEE-9226-45F5-A324-180E7B97D537Q34099106-A1718684-D804-42B6-AD13-4B66303B0013Q34191248-4B1FB44D-2869-42D4-91BB-862E5701233CQ34276512-C643D43F-0488-4145-BE7F-132657E84015Q34342982-6C0D6039-5B88-4105-BF04-D633C0E32E84Q34364103-71B2C326-F838-4319-A170-9EF063D5C96FQ34544058-A077785E-9641-4373-8504-BF71813B3DE9Q34772540-B4CF29FE-C53B-4AF5-88E1-579E96B93CF0Q35067616-656ED35A-AAC8-4C9F-A692-DB5D7FBD21C5Q35088971-6157DC2A-31A9-42F3-A997-1B4CEFB88127Q35123212-538876A1-5031-434E-8943-086A853568B9Q35201914-19362F54-58F2-4B8C-A1A6-D73DC311BA96Q35592959-0BBB59C2-5FD0-4C1A-A50C-78F5F703AC3AQ35834680-D11A1B3A-68C7-4162-A929-8003583354C3Q36043015-4B0AF444-5EE0-4E46-B9EF-31900DA1AEB0Q36371544-7239DE05-A5B9-4ABE-AE33-DB67A79B96EBQ36381918-C907A49D-A106-400B-AF48-CC757C88A1D3Q36399807-8D983398-4491-4BD3-9BE9-859908E1D85FQ36445855-C70BB710-719B-45A8-839B-4F8F60BA1A3EQ36483306-1193C7A1-FA01-49C9-96B2-DDB35A90C32FQ36498454-BD003E11-6567-4C7E-BAB5-4B0A6EC9D356Q36528989-1EDAE734-269E-477C-AC38-DA871BCDE316Q36983661-D040664C-3E16-4C9E-BB7E-2B19C3E3F8F6Q37000845-4512E4C8-EACC-436B-96DB-5C1500868783Q37145041-7328A8A5-0DCE-4DA2-ADE8-53EE05D92E91Q37160648-CBD76251-ACBE-4D55-9B36-864AD110B244Q37706835-04E35E86-3931-48DC-96CA-2BC6733A6CFCQ37962612-2ED13F56-391C-46F3-A00D-18503196FAC9Q38068470-2D4C8141-455A-434B-9DA2-4370F03A94D6Q39206746-7ECC76C6-609E-4C5A-AB4F-6A1924004EB7Q40135212-47D03076-200A-48E6-B75A-CE51C4365282Q40253271-94299EC4-F77F-4DA4-AEE1-4F54D83B8389Q45873308-F6D8CDCD-B506-4220-82A0-F948F9300DDD
P2860
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
@ast
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
@en
type
label
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
@ast
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
@en
prefLabel
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
@ast
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
@en
P2093
P2860
P356
P1476
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes.
@en
P2093
P2860
P304
P356
10.1084/JEM.191.3.541
P407
P577
2000-02-01T00:00:00Z